{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-023644","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.402691+00:00","generated_at":"2026-05-18T19:14:45.730131+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"PDS Biotechnology updates corporate presentation; no financial or clinical data disclosed","bullets":["Filed 8-K on June 25, 2025, with updated corporate presentation as Exhibit 99.1.","Presentation titled 'Addressing the Growing Incidence of HPV16-Related Cancers' and 'Precision Designed Science For Immunotherapy'.","No new financial results, clinical trial data, or guidance provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-023644","json":"https://secwatch.observer/filing/0001140361-25-023644.json","markdown":"https://secwatch.observer/filing/0001140361-25-023644.md","text":"https://secwatch.observer/filing/0001140361-25-023644.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125023644/0001140361-25-023644-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125023644/ef20051058_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T19:14:45.730131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}